Catalyst Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-422
Closed -$216K 124
2022
Q4
$216K Buy
+422
New +$214K 0.2% 119

Other funds holding ELV

Catalyst Wealth Management's ELV Position: Q1 2023 in Review

Catalyst Wealth Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 422 shares — an estimated $216K sold.

Catalyst Wealth Management first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $216K in Q4 2022. 1,517 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Catalyst Wealth Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Catalyst Wealth Management sold 422 Elevance Health shares in Q1 2023, an estimated $216K.
  • Catalyst Wealth Management first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
  • Catalyst Wealth Management's Elevance Health position peaked at $216K in Q4 2022.
  • 1,517 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Catalyst Wealth Management's 13F filing for Q1 2023, filed 11 Apr 2023.